What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
His primary areas of study are Surgery, Internal medicine, Chemotherapy, Radiation therapy and Temozolomide.
His research combines Clinical trial and Surgery.
His Internal medicine research includes themes of Gastroenterology, Astrocytoma and Oncology.
His Chemotherapy research integrates issues from Adverse effect and Aseptic meningitis.
His study in Radiation therapy is interdisciplinary in nature, drawing from both Vincristine, Nuclear medicine and Spinal cord.
His Radiology research focuses on Pathology and how it connects with Neurologic Oncology.
His most cited work include:
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group (2349 citations)
- Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology (653 citations)
- Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors Report of the Quality Standards Subcommittee of the American Academy of Neurology (653 citations)
What are the main themes of his work throughout his whole career to date?
Marc C. Chamberlain spends much of his time researching Internal medicine, Surgery, Chemotherapy, Oncology and Radiation therapy.
He focuses mostly in the field of Internal medicine, narrowing it down to matters related to Gastroenterology and, in some cases, Adverse effect and Survival rate.
Surgery and Glioma are commonly linked in his work.
His study focuses on the intersection of Chemotherapy and fields such as Pathology with connections in the field of Meningitis, Oligodendroglial Tumor and Neurology.
The Oncology study combines topics in areas such as Brain tumor, Breast cancer, Glioblastoma and Clinical endpoint.
His Radiation therapy research is classified as research in Radiology.
He most often published in these fields:
- Internal medicine (48.59%)
- Surgery (40.96%)
- Chemotherapy (37.85%)
What were the highlights of his more recent work (between 2013-2020)?
- Internal medicine (48.59%)
- Oncology (33.05%)
- Surgery (40.96%)
In recent papers he was focusing on the following fields of study:
Marc C. Chamberlain mainly focuses on Internal medicine, Oncology, Surgery, Temozolomide and Progression-free survival.
His study in the field of Lung cancer is also linked to topics like Capecitabine.
Marc C. Chamberlain combines topics linked to Clinical trial with his work on Surgery.
His Temozolomide study combines topics from a wide range of disciplines, such as Lomustine and Dacarbazine.
His research in Progression-free survival intersects with topics in Gastroenterology, Progressive disease and Phases of clinical research.
In Chemotherapy, Marc C. Chamberlain works on issues like Glioma, which are connected to Radiology and Pathology.
Between 2013 and 2020, his most popular works were:
- Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. (295 citations)
- Leptomeningeal metastases: a RANO proposal for response criteria. (114 citations)
- Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review (111 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
The scientist’s investigation covers issues in Internal medicine, Surgery, Oncology, Radiation therapy and Chemotherapy.
In his research on the topic of Internal medicine, Pertuzumab and Breast cancer is strongly related with Gastroenterology.
His Oncology research is multidisciplinary, incorporating elements of Adjuvant radiotherapy, Newly diagnosed, Cancer research and Alternating electric field therapy.
His studies deal with areas such as Vincristine, Procarbazine, Guideline and Glioma as well as Radiation therapy.
His Chemotherapy research incorporates elements of Neurology and Myopathy.
Within one scientific family, Marc C. Chamberlain focuses on topics pertaining to Cancer under Radiology, and may sometimes address concerns connected to Pathology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
